Client News
Destiny Pharma announces publication of XF-73 nasal gel Phase 2 data in leading US journal Infection Control & Hospital Epidemiology
24th March 2023
Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business
24th March 2023
InflaRx reports full year 2022 financial and operating results
22nd March 2023
A new prestigious scientific publication for Carbios marks the expansion of its research to other plastics
21st March 2023
Mainz Biomed to present at Sidoti Virtual Investor Conference March 22-23
21st March 2023
Rentschler Biopharma’s service excellence recognized with CDMO Leadership Awards and Champion status
20th March 2023
Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
20th March 2023
Andera Partners co-leads $25m extension round for FIRE1, an Irish medtech developing breakthrough technology for patients with heart failure
15th March 2023
Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
15th March 2023
ONWARD to publish full year 2022 financial results and host webcast on March 28, 2023
14th March 2023